Articles and Insights About Wearables for Clinical Trials

Digital Endpoints

VivoSense Awarded NIH/NCI Grant to Aid in Cancer Research

 Dudley Tabakin

VivoSense, Inc. is proud to announce that we have been awarded an NIH/NCI Phase 1 contract to develop software enabling data integration from wearable sensors for cancer patients. The contract will result in the development of the VivoSense Cancer Health Informatics Platform as the leading wearable sensor agnostic cloud platform for cancer research and clinical care.

Read More

Developing Digital Biomarkers Post Covid-19

 Dudley Tabakin

The 3rd Annual Digital Biomarkers in Clinical Trials Summit hosted by Roche was the virtual place to be in June, bringing together 250+ global thought leaders and experts. They shared insights on developing and improving the way pharma clinical trials utilize mobile-enabled, wearables, and IoT capabilities to augment existing biomarker strategies, improve patient experience, and collect better data.

Read More

Digital Biomarkers to Address COVID-19 Symptoms and Progression

 Dudley Tabakin

The US and international effort to address the novel Coronavirus (COVID-19) pandemic is unprecedented. Experts from healthcare, public health, and policy are joining forces with experts in manufacturing and technology for the rapid deployment of innovative, lifesaving solutions. VivoSense, an expert in remote monitoring of physiological signals, is contributing to this effort through their advanced data analytics and Human Augmented AI platform.

Read More

VivoSense® Plays Vital Role in Respiratory Monitoring in Infants

 VivoSense Team

Severe respiratory disease is one of the leading causes of infant illness and death worldwide. There is a significant upward trend of clinical infant respiratory studies, including the investigation into respiratory success in ventilated infants, SIDS, and neurological disorders that affect the normal respiratory pattern. In this article, we discuss how noninvasive respiratory monitoring and VivoSense® software helps researchers collect and analyze respiratory data for clinical studies focused on infant and neo-natal breathing patterns.

Read More

VivoSense® Provides the Solution to Accurate Volume Measures Derived from RIP

 Dudley Tabakin

Respiratory inductance plethysmography (RIP) is a method for evaluating breathing characteristics by measuring the movement of the thorax and abdominal wall. RIP acquires respiratory data via two elastic bands placed around the rib cage (RC) and abdomen (AB), and thus, must be calibrated to provide accurate volume metrics.

Read More

VivoSense Facilitates Novel Respiratory Studies in Premature Infants

 Dudley Tabakin

VivoSense continues to lead the way in infant respiratory analysis.

Orange County, CA, February, 2017 – Washington University School of Medicine, and St Louis Children’s Hospital with funding from the NIH Prematurity and Respiratory Outcomes Project (PROP) https://clinicaltrials.gov/ct2/show/NCT01435187 have published early research findings. The primary goal of the PROP study was to identify biomarkers and clinical variables in premature infants that would potentially predict pulmonary status up to one year later.

Read More

Vivonoetics to Provide Advanced Respiratory Assessment for SMA-1 Clinical Trial

 Dudley Tabakin

Roche’s Firefish clinical trial will evaluate drug efficacy against respiratory muscle function and breathing patterns in infants treated for SMA.

Orange County, CA, January, 2017 – Vivonoetics Inc., developer of VivoSense® respiratory testing solutions, announced today that in partnership with Great Lakes NeuroTechnologies, they will be providing advanced respiratory assessment to the Roche FIREFISH study.

Read More

Vivonoetics Partners with Beddit to Provide Contact-Free Monitoring of Sleep and Vital Signs

 Dudley Tabakin

Vivonoetics Inc., developer of VivoSense® clinical research management and analysis software, announced today that they have partnered with Beddit, Inc., leading innovators in contact-free sleep and vital sign monitoring technology. The partnership will provide pharmaceutical companies and research organizations a practical and cost effective solution for long-term monitoring of sleep and vital signs, enabling more effective and efficient evaluation of new and existing treatments.

Read More

Stay Connected

Popular